Single dose of rasburicase for treatment of hyperuricemia in acute kidney injury: A report of 3 cases

Iranian Journal of Kidney Diseases

Volumn 5, Issue 2, 2011, Pages 130-132

  Hooman, Nakysa ^a   Otukesh, Hasan ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute kidney injury; Hyperuricemia; Rasburicase; Recombinant urate oxidase

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CREATININE; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; RASBURICASE; TUBERCULOSTATIC AGENT; VANCOMYCIN; ANTIGOUT AGENT; URATE OXIDASE;

ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW BIOPSY; CASE REPORT; CHILD; CREATININE BLOOD LEVEL; DEHYDRATION; DIARRHEA; FEVER; GLOMERULONEPHRITIS; HEMODIALYSIS; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; HYPERURICEMIA; INFLAMMATION; LOW DRUG DOSE; MALE; NEPHRITIS; PANCYTOPENIA; PRESCHOOL CHILD; PYURIA; RASH; REHYDRATION; SCHOOL CHILD; SEPTIC SHOCK; SEROLOGY; SINGLE DRUG DOSE; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULOSIS; UNCONSCIOUSNESS; URIC ACID BLOOD LEVEL; URIC ACID NEPHROPATHY; URINE VOLUME; VOMITING; INFANT;

ACUTE KIDNEY INJURY; CHILD; CHILD, PRESCHOOL; GOUT SUPPRESSANTS; HUMANS; HYPERURICEMIA; INFANT; MALE; URATE OXIDASE;

EID: 79958751437     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Goldman SC, Holcenberg JS, Finklestein JZ, et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood. 2001;97:2998-3003.
2. Pui CH, Jeha S, Irwin D, Camitta B. Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult paients: results of a compassionate-use trial. Leukemia. 2001;15:1505-159.
3. Vogt B. Urate oxidase (rasburicase) for treatment of severe tophaceous gout. Nephrol Dial Transplant. 2005;20:431-433.
4. Segura Torres P, Borrego Utiel FJ, Perez Del Barrio P, Gil Cunquero JM, Perez Bariasco V. Efficacy of rasburicase therapy in obstructive renal failure secondary to urolithiasis: a novel therapeutic option. Nefrologia. 2008;28:102-105.
5. De Angelis S, Noce A, Di Renzo L, et al. Is rasburicase an effective alternative to allopurinol for management of hyperuricemia in renal failure patients? A double blind-randomized study. Eur Rev Med Pharmacol Sci. 2007;11:179-184.
6. Hobbs DJ, Steinke JM, Chung JY, Barletta GM, Bunchman TE. Rasburicase improves hyperuricemia in infants with acute kidney injury. Pediatr Nephrol. 2010;25:305-9.
7. Conger JD. Acute uric acid nephropathy. Med Clin North Am. 1990;74:859-871.
8. Kjellstrand CM, Campbell DC, von Hartitzsch B. Hyperuricemic acute renal failure. Arch Intern Med. 1974;133:349-359.
9. Ejaz AA, Mu W, Kang DH, et al. Could uric acid have a role in acute renal failure? Clin J Am Soc Nephrol. 2007;2:16-21.
10. Hooman N, Mehrazma M, Nakhaii S, et al. The value of serum uric acid as a mortality prediction in critically Ill children. Iran J Pediatr. 2010;20:323-329.
11. Pession A, Melchionda F, Castellini C. Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase). Biologics. 2008;2:129-141.